Overexpression of SOX5 has been shown to inhibit proliferation in both in vitro experiments of human glioma cell lines and in vivo experiments using platelet-derived growth factor β (PDGFβ)-induced glioma in mice (Tchougounova et al., 2009). The gene discussed is SOX5; the disease is central nervous system cancer.